Genomic profile of 320 uveal melanoma cases: Chromosome 8p-loss and metastatic outcome

Investigative Ophthalmology and Visual Science

Volumn 54, Issue 8, 2013, Pages 5721-5729

  Ewens, Kathryn G ^a   Kanetsky, Peter A ^a   Richards Yutz, Jennifer ^a   Al Dahmash, Saad ^a   de Luca, Maria Carla ^b   Bianciotto, Carlos G ^b   Shields, Carol L ^b   Ganguly, Arupa ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Chromosome changes; Marker; Prognosis; SNP arrays; Uveal melanoma

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; CHILD; CHROMOSOME 1; CHROMOSOME 3; CHROMOSOME 6; CHROMOSOME 8P; CHROMOSOME LOSS; COPY NUMBER VARIATION; FEMALE; FINE NEEDLE ASPIRATION BIOPSY; GENDER; GENETIC ASSOCIATION; GENETIC SCREENING; GENOME ANALYSIS; HUMAN; MAJOR CLINICAL STUDY; MALE; METASTASIS; MICROARRAY ANALYSIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR VOLUME; UVEA MELANOMA;

CHROMOSOME CHANGES; MARKER; PROGNOSIS; SNP ARRAYS; UVEAL MELANOMA;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BIOPSY, FINE-NEEDLE; CHILD; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 8; DNA; FEMALE; FOLLOW-UP STUDIES; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; MALE; MELANOMA; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; RETROSPECTIVE STUDIES; TIME FACTORS; UVEAL NEOPLASMS; YOUNG ADULT;

EID: 84883002692     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.13-12195     Document Type: Article

References (46)

1. Kujala E, M̈akitie T, Kivel̈a T. Very long-term prognosis of patients with malignant uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44:4651-4659.
2. Paul EV, Parnell BL, Fraker M. Prognosis of malignant melanomas of the choroid and ciliary body. Int Ophthalmol Clin. 1962;2:387-402.
3. Eskelin S, Pyrḧonen S, Hahka-Kemppinen M, et al. A prognostic model and staging for metastatic uveal melanoma. Cancer. 2003;97:465-475.
4. Lorigan JG, Wallace S, Mavligit, GM. The prevalence and location of metastases from ocular melanoma: imaging study in 110 patients. AJR Am J Roentgenol. 1991;157:1279-1281.
5. Kodjikian L, Nguyen K, Lumbroso L, et al. Familial uveal melanoma: a report on two families and a review of the literature. Acta Ophthalmol Scand. 2003;81:389-395.
6. Singh AD, Shields CL, De Potter P, et al. Familial uveal melanoma. Clinical observations on 56 patients. Arch Ophthalmol. 1996;114:392-399.
7. Damato B, Coupland SE. A reappraisal of the significance of largest basal diameter of posterior uveal melanoma. Eye. 2009;23:2152-2162.
8. Damato B, Eleuteri A, Taktak AFG, Coupland SE. Estimating prognosis for survival after treatment of choroidal melanoma. Prog Retin Eye Res. 2011;30:285-295.
9. Shields CL, Furuta M, Thangappan A, et al. Metastasis of uveal melanoma millimeter-by-millimeter in 8033 consecutive eyes. Arch Ophthalmol. 2009;127:989-998.
10. Shields JA, Shields CL. Prognostic factors for uveal melanoma. In: Gospodarowicz M, O'Sullivan B, Sobin LH, eds. Prognostic Factors in Cancer. 3rd ed. Hoboken, NJ: Wiley-Liss, Inc.; 2006;269-272.
11. Horsman DE, Sroka H, Rootman J, White VA. Monosomy 3 and isochromosome 8q in a uveal melanoma. Cancer Genet Cytogenet. 1990;45:249-253.
12. Wiltshire RN, Elner VM, Dennis T, et al. Cytogenetic analysis of posterior uveal melanoma. Cancer Genet Cytogenet. 1993;66:47-53.
13. Sisley K, Rennie IG, Parsons MA, et al. Abnormalities of chromosomes 3 and 8 in posterior uveal melanoma correlate with prognosis. Genes Chromosomes Cancer. 1997;19:22-28.
14. Speicher MR, Prescher G, du Manoir S, et al. Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization. Cancer Res. 1994;54:3817-3823.
15. Aalto Y, Eriksson L, Seregard S, et al. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma. Invest Ophthalmol Vis Sci. 2001;42:313-317.
16. Gordon KB, Thompson CT, Char DH, et al. Comparative genomic hybridization in the detection of DNA copy number abnormalities in uveal melanoma. Cancer Res. 1994;54:4764-4768.
17. Shields CL, Ganguly A, Materin MA, et al. Chromosome 3 analysis of uveal melanoma using fine-needle aspiration biopsy at the time of plaque radiotherapy in 140 consecutive cases: the Deborah Iverson, MD, lectureship. Arch Ophthalmol. 2007;125:1017-1024.
18. Tschentscher F, Prescher G, Zeschnigk M, et al. Identification of chromosomes 3, 6, and 8 aberrations in uveal melanoma by microsatellite analysis in comparison to comparative genomic hybridization. Cancer Genet Cytogenet. 2000;122:13-17.
19. Damato B, Dopierala JA, Coupland SE. Genotypic profiling of 452 choroidal melanomas with multiplex ligation-dependent probe amplification. Clin Cancer Res. 2010;16:6083-6092.
20. Vaarwater J, van den Bosch T, Mensink HW, et al. Multiplex ligation-dependent probe amplification equals fluorescence insitu hybridization for the identification of patients at risk for metastatic disease in uveal melanoma. Melanoma Res. 2012;22:30-37.
21. Lake SL, Coupland SE, Taktak AFG, Damato BE. Whole-genome microarray detects deletions and loss of heterozygosity of chromosome 3 occurring exclusively in metastasizing uveal melanoma. Invest Ophthalmol Vis Sci. 2010;51:4884-4891.
22. Singh AD, Aronow ME, Sun Y, et al. Chromosome 3 status in uveal melanoma: a comparison of fluorescence in situ hybridization and single-nucleotide polymorphism array. Invest Ophthalmol Vis Sci. 2012;53:3331-3339.
23. Prescher G, Bornfeld N, Becher R. Nonrandom chromosomal abnormalities in primary uveal melanoma. J Natl Cancer Inst. 1990;82:1765-1769.
24. Prescher G, Bornfeld N, Hirche H, et al. Prognostic implications of monosomy 3 in uveal melanoma. Lancet. 1996;347:1222-1225.
25. Damato B, Dopierala J, Klaasen A, et al. Multiplex ligationdependent probe amplification of uveal melanoma: correlation with metastatic meath. Invest Ophthalmol Vis Sci. 2009;50:3048-3055.
26. Damato B, Duke C, Coupland SE, et al. Cytogenetics of uveal melanoma: a 7-year clinical experience. Ophthalmology. 2007;114:1925-1931.
27. Kilic E, Naus NC, van Gils W, et al. Concurrent loss of chromosome arm 1p and chromosome 3 predicts a decreased disease-free survival in uveal melanoma patients. Invest Ophthalmol Vis Sci. 2005;46:2253-2257.
28. Onken MD, Worley LA, Harbour JW. A metastasis modifier locus on human chromosome 8p in uveal melanoma identified by integrative genomic analysis. Clin Cancer Res. 2008;14:3737-3745.
29. van den Bosch T, van Beek JGM, Vaarwater J, et al. Higher percentage of FISH-determined monosomy 3 and 8q amplification in uveal melanoma cells relate to poor patient prognosis. Invest Ophthalmol Vis Sci. 2012;53:2668-2674.
30. White VA, Chambers JD, Courtright PD, et al. Correlation of cytogenetic abnormalities with the outcome of patients with uveal melanoma. Cancer. 1998;83:354-359.
31. Onken MD, Worley LA, Char DH, et al. Collaborative Ocular Oncology Group report number 1: prospective validation of a multi-gene prognostic assay in uveal melanoma. Ophthalmology. 2012;119:1596-1603.
32. Onken MD, Worley LA, Ehlers JP, Harbour JW. Gene expression profiling in uveal melanoma reveals two molecular classes and predicts metastatic death. Cancer Res. 2004;64:7205-7209.
33. Onken MD, Worley LA, Tuscan MD, Harbour JW. An accurate, clinically feasible multi-gene expression assay for predicting metastasis in uveal melanoma. J Mol Diagn. 2010;12:461-468.
34. Worley LA, Onken MD, Person E, et al. Transcriptomic versus chromosomal prognostic markers and clinical outcome in uveal melanoma. Clin Cancer Res. 2007;13:1466-1471.
35. van Gils W, Lodder EM, Mensink HW, et al. Gene expression profiling in uveal melanoma: two regions on 3p related to prognosis. Invest Ophthalmol Vis Sci. 2008;49:4254-4262.
36. Shields CL, Ganguly A, Bianciotto CG, et al. Prognosis of uveal melanoma in 500 cases using genetic testing of fine-needle aspiration biopsy specimens. Ophthalmology. 2011;118:396-401.
37. Shields CL, Materin MA, Teixeira L, et al. Small choroidal melanoma with chromosome 3 monosomy on fine-needle aspiration biopsy. Ophthalmology. 2007;114:1919-1924.
38. Shields CL, Ramasubramanian A, Ganguly A, et al. Cytogenetic testing of iris melanoma using fine needle aspiration biopsy in 17 patients. Retina. 2011;31:574-580.
39. Sisley K, Nichols C, Parsons MA, et al. Clinical applications of chromosome analysis, from fine needle aspiration biopsies, of posterior uveal melanomas. Eye. 1998;12:203-207.
40. Naus NC, Verhoeven ACA, van Drunen E, et al. Detection of genetic prognostic markers in uveal melanoma biopsies using fluorescence in situ hybridization. Clin Cancer Res. 2002;8:534-539.
41. Damato B, Lecuona K. Conservation of eyes with choroidal melanoma by a multimodality approach to treatment: an audit of 1632 patients. Ophthalmology. 2004;111:977-983.
42. Shields JA, Shields CL, De Potter, P, Singh AD. Diagnosis and treatment of uveal melanoma. Semin Oncol. 1996;23:763-767.
43. Coupland SE, Lake SL, Zeschnigk M, Damato BE. Molecular pathology of uveal melanoma. Eye. 2013;27:230-242.
44. Schoenfield L, Pettay J, Tubbs RR, et al. Variation of monosomy 3 status within uveal melanoma. Arch Path Lab Med. 2009;133:1219-1222.
45. Bronkhorst IHG, Maat W, Jordanova ES, et al. Effect of heterogeneous distribution of monosomy 3 on prognosis in uveal melanoma. Arch Path Lab Med. 2011;135:1042-1047.
46. Harbour JW. The genetics of uveal melanoma: an emerging framework for targeted therapy. Pigment Cell Melanoma Res. 2012;25:171-181.